UNSPSC 85815416: Introduction of serum, toxoid and vaccine into central artery, open approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of serum, toxoid and vaccine into central artery, open approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0604Z

UNSPSC 85815416 Introduction of serum, toxoid and vaccine into central artery, open approach is a Commodity code with minimal recent relevant activity in state and local procurement. The code's clinical framing—a procedure-specific medical intervention—does not align with the scope of recent opportunities posted under this taxonomy code. The opportunities tagged to UNSPSC 85815416 span virtual urgent care services, occupational health screenings, cancer registry operations, retinal imaging devices, EMS staffing, employee health clinics, wellness platforms, behavioral health services, and opioid treatment programs. None of these solicitations describe or procure the specific procedure named in the code. This taxonomy mismatch suggests either miscoding by issuing bodies or that the code is not actively used for state and local health service procurement in practice.

The issuing bodies posting under or near this code range across state health departments (Nevada Health Authority, Colorado Department of Human Services, Texas HHSC, New Jersey Department of Health), county health systems (Santa Clara, San Mateo, Ventura, Seminole, Boulder), municipal health agencies (City of Ocala, City of Phoenix, City of Atlanta), and special-purpose entities (Rockland County Department of Mental Health, Events DC). Activity clusters around occupational health, behavioral health, opioid use disorder services, emergency medical services support, and employee wellness—none targeting intra-arterial vaccine administration. Geographic spread across recent postings includes California, Colorado, Florida, Georgia, Illinois, Kansas, Missouri, Nevada, New Jersey, New York, Oregon, Texas, and the District of Columbia. Pursuit of this code is not recommended without clarity from the issuing body that the actual scope aligns with the code's clinical definition.